IASAX | JVMSX | IASAX / JVMSX | |
Total Expense Ratio | 1.35 | 1.24 | 109% |
Annual Report Gross Expense Ratio | 1.63 | 1.25 | 130% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | -5.236 | 10.593 | -49% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 273M | 23.9B | 1% |
Annual Yield % from dividends | 1.70 | 0.40 | 427% |
Returns for 1 year | -7.83 | -4.30 | 182% |
Returns for 3 years | -0.23 | 25.80 | -1% |
Returns for 5 years | 5.43 | 48.32 | 11% |
Returns for 10 years | -2.57 | 48.25 | -5% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 16.84 | 0.34 | +2.06% |
abrdn Life Sciences Investors | |||
OMAH | 19.24 | 0.21 | +1.10% |
Vistashares Target 15 Berkshire Select Income ETF | |||
GUNR | 43.95 | 0.40 | +0.92% |
FlexShares Mstar Glbl Upstrm Nat Res ETF | |||
XIDE | 30.32 | 0.03 | +0.11% |
FT Vest U.S. Eq Buf & PrmIncETF-Dec | |||
RWM | 16.38 | -0.32 | -1.92% |
ProShares Short Russell2000 |